Skip to main content
    M

    Madrigal Pharmaceuticals Inc (MDGL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $421.99
    -1.97 (-0.46%)

    Market Cap: $9.93B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Madrigal Pharmaceuticals Inc (MDGL) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Madrigal Pharmaceuticals (MDGL) has a latest price of $421.99 on Nov 17, 2026, 31.4% below its 52-week high of $615.00. Its price fell 20.3% over the past 12 months. The month-end price rose 2,508.2% over the 10 years through Oct 2026, a compound annual rate of 38.6%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $596.98 in Nov 2025 and its lowest $14.90 in Dec 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart MDGL with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for MDGL.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 21.9%, and over 6 months it fell 17.6%. The month-end price rose 227.6% over the 3 years through Oct 2026, a compound annual rate of 48.5%.

    PeriodChange
    1 month-5.6%
    3 months-21.9%
    6 months-17.6%
    12 months-20.3%
    12 months, with dividends-20.3%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+227.6%+48.5%
    5 years+453.5%+40.8%
    10 years+2,508.2%+38.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 516.0%, and its weakest was 2021, when it fell 23.8%.

    YearCloseChange
    2026 through Oct 2026$430.36-26.1%
    2025$582.34+88.7%
    2024$308.57+33.4%
    2023$231.38-20.3%
    2022$290.25+242.5%
    2021$84.74-23.8%
    2020$111.17+22.0%
    2019$91.11-19.2%
    2018$112.72+22.8%
    2017$91.79+516.0%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 10.4% below its 50-day average of $471.14 and 14.8% below its 200-day average of $495.33.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$421.99
    52-week high$615.00-31.4%
    52-week low$353.54+19.4%
    50-day average$471.14-10.4%
    200-day average$495.33-14.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 34.3%.

    MeasureValue
    1-year beta0.44
    Largest fall, 1 year-34.3%
    Largest fall, 3 years-34.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About MDGL

    What is MDGL's 1-year price change?

    Madrigal Pharmaceuticals's price fell 20.3% over the past 12 months. With dividends included, the 12-month total return was -20.3%.

    What is MDGL's 5-year price change?

    Madrigal Pharmaceuticals's month-end price rose 453.5% over the 5 years through Oct 2026, a compound annual rate of 40.8%. These figures leave out dividends.

    What is MDGL's 52-week high and low?

    Madrigal Pharmaceuticals's 52-week high is $615.00 and its 52-week low is $353.54. Its latest price of $421.99 on Nov 17, 2026 is 31.4% below the high.

    What is MDGL's beta?

    Madrigal Pharmaceuticals's 1-year beta against the S&P 500 is 0.44, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 34.3%.

    Is the MDGL chart free?

    Yes. Advanced Charting for MDGL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.